14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of COLL
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Collegium Pharmaceutical stock upgraded to Hold/Accumulate.
(Updated on Apr 23, 2024)

Hold candidate since Apr 23, 2024 PDF

The Collegium Pharmaceutical stock price gained 3.45% on the last trading day (Tuesday, 23rd Apr 2024), rising from $34.74 to $35.94. During the last trading day the stock fluctuated 4.53% from a day low at $34.92 to a day high of $36.51. The price has fallen in 6 of the last 10 days and is down by -7.35% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 183 thousand more shares were traded than the day before. In total, 545 thousand shares were bought and sold for approximately $19.58 million.

The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $34.83 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 14.97% during the next 3 months and, with a 90% probability hold a price between $40.04 and $48.88 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

COLL Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, April 22, 2024, and so far it has risen 3.45%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Collegium Pharmaceutical stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $37.83. On a fall, the stock will find some support from the short-term average at $35.18. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Collegium Pharmaceutical stock

Collegium Pharmaceutical finds support from accumulated volume at $35.71 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.58 between high and low, or 4.53%. For the last week, the stock has had daily average volatility of 2.95%.

Our recommended stop-loss: $34.10 (-5.13%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 1 day ago.)

Trading Expectations (COLL) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Collegium Pharmaceutical to open at $35.79, and during the day (based on 14 day Average True Range), to move between $34.77 and $37.11, which gives a possible trading interval of +/-$1.17 (+/-3.26%) up or down from last closing price. If Collegium Pharmaceutical takes out the full calculated possible swing range there will be an estimated 6.52% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $35.71 (0.64%) than the resistance at $36.35 (1.14%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Collegium Pharmaceutical stock A Buy?

Collegium Pharmaceutical holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: 0.187 Hold/Accumulate Upgraded

Predicted Opening Price for Collegium Pharmaceutical of Wednesday, April 24, 2024

Fair opening price April 24, 2024 Current price
$35.79 ( 0.419%) $35.94

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for COLL

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 37.37 3.98 %
R2 36.77 2.30 %
R1 36.39 1.26 %
Current price: 35.94
Support S1 35.18 -2.10 %
S2 34.81 -3.14 %
S3 34.21 -4.82 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 39.09 8.76 %
R2 36.56 1.73 %
R1 36.35 1.14 %
Current price 35.94
Support S1 35.71 -0.640%
S2 34.74 -3.34%
S3 31.76 -11.63%

FAQ

What is the symbol for Collegium Pharmaceutical Stock and on which exchange is it traded?
The symbol for Collegium Pharmaceutical is COLL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Collegium Pharmaceutical Stock?
Collegium Pharmaceutical holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Collegium Pharmaceutical Stock?
Collegium Pharmaceutical Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Collegium Pharmaceutical Stock.

What's the current price of Collegium Pharmaceutical Stock?
As of the end of day on the Apr 23, 2024, the price of an Collegium Pharmaceutical (COLL) share was $35.94.

What is the 52-week high and low for Collegium Pharmaceutical Stock?
The 52-week high for Collegium Pharmaceutical Stock is $40.91 and the 52-week low is $20.84.

What is the market capitalization of Collegium Pharmaceutical Stock?
As of the Apr 23, 2024, the market capitalization of Collegium Pharmaceutical is 1.149B.

When is the next earnings date for Collegium Pharmaceutical?
The upcoming earnings date for Collegium Pharmaceutical is May 02, 2024.
Click to get the best stock tips daily for free!

About Collegium Pharmaceutical

Collegium Pharmaceutical Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatm... COLL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT